Webinar: Why Patient-Specific Insulin Dosing Matters. Register Now
About Monarch Medical Technologies
Our company
Driving innovation for over 20 years
For more than two decades, we’ve been leading the way in insulin management technology.
From the very beginning, our focus has remained the same—to empower nurses with a simplified process for insulin management; and to support hospitals in enhancing patient safety.
20
Years of experience
3,800
Dosing calculations every day
8/10
Top health systems choose EndoTool
Our story
This is our story
2003
MD Scientific was founded, laying the groundwork for developing the EndoTool glucose management system and future innovations in glycemic management.
2006
EndoTool receives FDA clearance and becomes available nationwide. The first implementation goes live at Carolina’s Medical Center (now part of Atrium Health).
2008
Hospira acquired EndoTool, expanding its reach and impact in the healthcare industry.
2012
EndoTool was acquired by Eigen Capital, leading to the foundation of Monarch Medical Technologies.
2014
The launch and FDA clearance of EndoTool’s patented Estimated Residual Extracellular Insulin (EREI) calculation sets a new standard for safety in glucose management systems, proving effective irrespective of kidney function.
2015
EndoTool SubQ receives FDA clearance, broadening the scope of glycemic management solutions available to healthcare providers.
2019
Salinas and Mendez report EndoTool's significant safety and efficacy, particularly in reducing the risk of hypoglycemia compared to other electronic glucose management systems published in the Journal of Diabetes Science and Technology.
2020
Monarch Medical Technologies supports healthcare systems during the COVID-19 pandemic, providing essential tools for managing critically ill patients' glucose levels. This included many of our nurses joining frontline workers to support the cause.
2021
EndoTool SubQ is enhanced with new features, including multiple dosing modes. These improvements receive FDA clearance, offering greater flexibility and precision in glycemic management.
2022
Monarch Medical Technologies reaches a milestone, with 8 of the top 10 healthcare systems in the country becoming our customers.
2024
Undergoing a significant rebranding, Monarch Medical Technologies and EndoTool unveil a fresh identity as the leaders in patient specific insulin dosing.
What drives us
Our vision
A world where every inpatient insulin dose is the right one.
Our mission
To better the lives of hospital personnel and their patients by delivering safe and simple personalized insulin therapy, enabled by technology.
Our core values and beliefs
People first
Above all, we exist to help people. We are empathetic and put people at the heart of every decision we make and action we take.
Stay true
We act with purpose and integrity. We stay true to our word, ourselves, and our customers. We don’t sacrifice substance for style.
Think big
We are open-minded and intellectually curious. Eager to learn and grow, we are passionate about creating a bright future for all.
Keep it simple
Healthcare is complex and demanding work. This is why we are always seeking new ways to provide a customer and user experience that feels brilliantly simple.
Careers
Looking for a career at Monarch Medical Technologies?
We’re committed to innovation in insulin management, building solutions that improve patient care. Join Monarch Medical Technologies and help shape the future of healthcare.
Our people
Leadership team
Charles Cornish
Chief Executive Officer
Sharai Lavoie
MBA, CPA, CGMA
Chief Financial Officer
Paul Chidester
MD, FACP
Chief Medical Officer
Matt Metcalf
Senior Vice President, Technology
Tara Burnett
MS, RAC, CQA, CQM/OE
Senior Vice President, Regulatory Affairs & Compliance
Shymaa Abdelaaty
Senior Vice President, Operations
Nicola Hunter
Senior Vice President, Marketing and Communications
Our trusted advisors
Clinical advisory board
Our clinical advisory board is composed of physicians with significant experience in fields like endocrinology, pulmonology, and medical research. This board provides Monarch Medical Technologies with more than 190 years of combined expertise, supporting our ongoing innovation and development of clinical solutions.
Joseph A. Aloi
MD
Section Chief of Endocrinology and Metabolism, Wake Forest Baptist Health / Past Chair of the American Diabetes Technology Interest Group
Dorothy Kodzwa
MD
Endocrinologist, CaroMont Regional Medical Center
James S. Lee
MD
Lead Physician in the Progressive Care Unit and a Hospitalist, Northside Hospital Gwinnet
Anthony Pick
MD, CDE
Assistant Professor of Endocrinology, Northwestern University
Andrew J. Behnke
MD
Section Chief of Endocrinology, Carilion Clinic / Associate Professor of Medicine, Virginia Tech Carilion School of Medicine
T. Glen Bouder
MD
Director of Valley Intensivists and Valley Health Pulmonary Specialists, Valley Health / Medical Director of Critical Care, Winchester Medical Center
Gregory Deines
DO
Division Chief of Diabetes and Endocrinology, Spectrum Health
Patrick Burgess
MD, PHD
Founder and Inventor of EndoTool
Become a partner
Let’s advance glycemic care together
We’re on a mission to solve insulin dosing challenges across healthcare systems. We welcome partnerships with organizations that are committed to enhancing glycemic management and driving superior clinical, economic, and safety outcomes.
Work with best-in-class glycemic management provider
Stay ahead of the market and increase the value you deliver to your customers.
Opportunities to deepen customer engagement
Attract new customers and offer new growth opportunities to existing customers.
Scale your team’s efforts with our partner resources
Tap into our existing ecosystem with joint marketing, and support from sales.
